| Trial | TALISMAN |
|---|---|
| Cancer Type | Myeloma |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase 2, Open-Label, Randomised Study To Evaluate Prophylactic Interventions On Talquetamab-Related Oral Toxicity |
| Trial Open | Yes |
 |
Click Here to view trial summary |